Abstract
Scott M. Silvers, Courtney Blayke Gibson, Christie Lech, Benjamin W. Friedman, Deborah B. Diercks, John D. Anderson, Michael D. Brown, Richard Byyny, Christopher R. Carpenter, Daniel Freess, Seth R. Gemme, Charles J. Gerardo, Joshua Gibson, Steven A. Godwin, Benjamin W. Hatten, Jason S. Haukoos, Sean M. Hickey, Gabe Kelen, Heemun Kwok, Christie Anne Lech, Abigail Leibowitz, Joyce Li, Bernard Lo, Amal Mattu, Susan B. Promes, Kaushal H. Shah, Richard D. Shih, Molly Thiessen, Christian Tomaszewski, Stacy A. Trent, Jonathan H. Valente, Lauren M. Westafer, Stephen P. Wall, Yanling Yu, Travis Schulz
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2008
Venous thromboembolism: a public health concern
10.1016/j.amepre.2009.12.017 · 2010
Key findings from multisite implementation of electronic health record tools for clinical pretest probability of pulmonary embolism in the emergency department
10.1177/1358863x251337456 · 2025
Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism
10.1164/rccm.200908-1204oc · 2010
The epidemiology of venous thromboembolism in the community
10.1161/atvbaha.108.162545 · 2008
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology
10.1016/j.amjmed.2004.01.018 · 2004
Antithrombotic therapy for venous thromboembolism
10.1001/jama.2022.7325 · 2022
Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the U.S
10.1182/blood.v106.11.910.910 · 2005
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality
10.1160/th07-03-0212 · 2007
Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial
10.1164/rccm.201512-2494oc · 2016
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
10.1016/s0140-6736(11)60824-6 · 2011
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial
10.1160/th16-01-0004 · 2016
Outpatient versus inpatient treatment for acute pulmonary embolism
10.1002/14651858.cd010019.pub2 · 2014
Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis
10.1093/eurheartj/ehab329 · 2021
Trends in discharge rates for acute pulmonary embolism in U.S. emergency departments
10.7326/m23-2442 · 2024
Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease
10.1016/j.annemergmed.2018.03.006 · 2018
Home treatment in pulmonary embolism
10.1016/j.thromres.2009.09.026 · 2010
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1186/s13643-021-01626-4 · 2021
Monotherapy anticoagulation to expedite home treatment of patients diagnosed with venous thromboembolism in the emergency department: a pragmatic effectiveness trial
10.1161/circoutcomes.120.007600 · 2021
Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis
10.1182/bloodadvances.2019001223 · 2020
Outpatient versus inpatient treatment for acute pulmonary embolism
2022
Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance
10.2147/ppa.s104446 · 2016
Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules
10.1016/j.thromres.2018.05.008 · 2018
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
10.1093/eurheartj/ehab373 · 2021
Outpatient treatment of low-risk pulmonary embolism in the era of direct oral anticoagulants: a systematic review
10.1111/acem.14108 · 2021
Safety, efficacy, length of stay and patient satisfaction with outpatient management of low-risk pulmonary embolism patients - a meta-analysis
10.5114/aoms/99206 · 2021
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN guideline for the evaluation and management of acute pulmonary embolism in adults: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
10.1016/j.jacc.2025.11.005 · 2026
2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN guideline for the evaluation and management of acute pulmonary embolism in adults: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
10.1016/j.jacc.2025.11.005 · doi-reference
Safety, efficacy, length of stay and patient satisfaction with outpatient management of low-risk pulmonary embolism patients - a meta-analysis
10.5114/aoms/99206 · doi-reference
Outpatient treatment of low-risk pulmonary embolism in the era of direct oral anticoagulants: a systematic review
10.1111/acem.14108 · doi-reference
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
10.1093/eurheartj/ehab373 · doi-reference
Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules
10.1016/j.thromres.2018.05.008 · doi-reference
Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinician acceptance
10.2147/ppa.s104446 · doi-reference
Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis
10.1182/bloodadvances.2019001223 · doi-reference
Monotherapy anticoagulation to expedite home treatment of patients diagnosed with venous thromboembolism in the emergency department: a pragmatic effectiveness trial
10.1161/circoutcomes.120.007600 · doi-reference
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
10.1186/s13643-021-01626-4 · doi-reference
Home treatment in pulmonary embolism
10.1016/j.thromres.2009.09.026 · doi-reference
Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease
10.1016/j.annemergmed.2018.03.006 · doi-reference
Trends in discharge rates for acute pulmonary embolism in U.S. emergency departments
10.7326/m23-2442 · doi-reference
Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis
10.1093/eurheartj/ehab329 · doi-reference
Outpatient versus inpatient treatment for acute pulmonary embolism
10.1002/14651858.cd010019.pub2 · doi-reference
Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial
10.1160/th16-01-0004 · doi-reference
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
10.1016/s0140-6736(11)60824-6 · doi-reference
Efficacy and safety of outpatient treatment based on the hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism. A randomized clinical trial
10.1164/rccm.201512-2494oc · doi-reference
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality
10.1160/th07-03-0212 · doi-reference
Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the U.S
10.1182/blood.v106.11.910.910 · doi-reference
Antithrombotic therapy for venous thromboembolism
10.1001/jama.2022.7325 · doi-reference
Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology
10.1016/j.amjmed.2004.01.018 · doi-reference
The epidemiology of venous thromboembolism in the community
10.1161/atvbaha.108.162545 · doi-reference
Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism
10.1164/rccm.200908-1204oc · doi-reference
Key findings from multisite implementation of electronic health record tools for clinical pretest probability of pulmonary embolism in the emergency department
10.1177/1358863x251337456 · doi-reference
Venous thromboembolism: a public health concern
10.1016/j.amepre.2009.12.017 · doi-reference